by Clinical Neuropsychologist Online | Wednesday, May 8, 2024 | Neuropsychology (general)
Volume 39, Issue 1, January 2025, Page 64-82. If you do not see content above, kindly GO TO SOURCE. Not all publishers encode content in a way that enables republishing at Neuro.vip. This post is Copyright: Cláudia Sousa Teresa Jacques Márcia França Patrícia Campos...
by Clinical Neuropsychologist Online | Wednesday, May 8, 2024 | Dementia
Abstract INTRODUCTION The impact of early-life tobacco exposure on dementia has remained unknown. METHODS Using the UK Biobank, the associations of maternal smoking during pregnancy (MSDP) and age of smoking initiation (ASI) with the onset time of all-cause dementia...
by Clinical Neuropsychologist Online | Wednesday, May 8, 2024 | Dementia
Abstract INTRODUCTION Cerebrovascular dysfunction is a pathological hallmark of Alzheimer’s disease (AD). Nevertheless, detecting cerebrovascular changes within bulk tissues has limited our ability to characterize proteomic alterations from less abundant cell...
by Clinical Neuropsychologist Online | Wednesday, May 8, 2024 | Dementia
Abstract BACKGROUND Alzheimer’s disease (AD) is the most common cause of dementia worldwide, with apolipoprotein Eε4 (APOEε4) being the strongest genetic risk factor. Current clinical diagnostic imaging focuses on amyloid and tau; however, new methods are needed...
by Clinical Neuropsychologist Online | Wednesday, May 8, 2024 | Dementia
Abstract INTRODUCTION Platelets serve as the primary peripheral reservoir of amyloid beta (Aβ). However, there is limited research on platelet markers in routine blood examinations, particularly with regard to the large platelet ratio (P-LCR) in Alzheimer’s...
